{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:10:37Z","timestamp":1782789037172,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224643\/Z\/21\/Z"],"award-info":[{"award-number":["224643\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000310","name":"Retina UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Gyrate atrophy of the choroid and retina is a rare autosomal recessive metabolic disorder caused by biallelic variants in the\n                      <jats:italic>OAT<\/jats:italic>\n                      gene, encoding the enzyme ornithine \u03b4-aminotransferase. Impaired enzymatic activity leads to systemic hyperornithinaemia, which in turn underlies progressive chorioretinal degeneration. In this study, we describe the clinical and molecular findings in a cohort of individuals with gyrate atrophy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Study participants were recruited through a tertiary UK clinical ophthalmic genetic service. All cases had a biochemical and molecular diagnosis of gyrate atrophy. Retrospective phenotypic and biochemical data were collected using electronic healthcare records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>18 affected individuals from 12 families (8 male, 10 female) met the study inclusion criteria. The median age at diagnosis was 8\u00a0years (range 10\u00a0months \u2013 33\u00a0years) and all cases had hyperornithinaemia (median: 800 micromoles\/L; range: 458\u20131244 micromoles\/L). Common features at presentation included high myopia (10\/18) and nyctalopia (5\/18). Ophthalmic findings were present in all study participants who were above the age of 6\u00a0years. One third of patients had co-existing macular oedema and two thirds developed pre-senile cataracts. Compliance with dietary modifications was suboptimal in most cases. A subset of participants had extraocular features including a trend towards reduced fat-free mass and developmental delay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings highlight the importance of multidisciplinary care in families with gyrate atrophy. Secondary ophthalmic complications such as macular oedema and cataract formation are common. Management of affected individuals remains challenging due to the highly restrictive nature of the recommended diet and the limited evidence-base for current strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02840-0","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T08:44:34Z","timestamp":1693817074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical, biochemical and molecular analysis in a cohort of individuals with gyrate atrophy"],"prefix":"10.1186","volume":"18","author":[{"given":"Eleanor","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina M.","family":"Stepien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Iosifidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunabha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Broomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Woodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0986-4123","authenticated-orcid":false,"given":"Panagiotis I.","family":"Sergouniotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"issue":"1","key":"2840_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/biology6010018","volume":"6","author":"A Ginguay","year":"2017","unstructured":"Ginguay A, Cynober L, Curis E, Nicolis I. Ornithine aminotransferase, an important glutamate-metabolizing enzyme at the crossroads of multiple metabolic pathways. Biology. 2017;6(1):18.","journal-title":"Biology"},{"issue":"2","key":"2840_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jimd.12180","volume":"43","author":"L Rumping","year":"2020","unstructured":"Rumping L, Vringer E, Houwen RHJ, van Hasselt PM, Jans JJM, Verhoeven-Duif NM. Inborn errors of enzymes in glutamate metabolism. J Inherit Metab Dis. 2020;43(2):200\u201315.","journal-title":"J Inherit Metab Dis"},{"issue":"14","key":"2840_CR3","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1111\/febs.14843","volume":"286","author":"R Montioli","year":"2019","unstructured":"Montioli R, Paiardini A, Giardina G, Zanzoni S, Cutruzzola F, Cellini B, et al. R180T variant of \u03b4-ornithine aminotransferase associated with gyrate atrophy: biochemical, computational, X-ray and NMR studies provide insight into its catalytic features. FEBS J. 2019;286(14):2787\u201398.","journal-title":"FEBS J"},{"issue":"11","key":"2840_CR4","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1016\/j.bbadis.2018.08.032","volume":"1864","author":"R Montioli","year":"2018","unstructured":"Montioli R, Desbats MA, Grottelli S, Doimo M, Bellezza I, Borri Voltattorni C, et al. Molecular and cellular basis of ornithine \u03b4-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina. Biochim Biophys Acta BBA Mol Basis Dis. 2018;1864(11):3629\u201338.","journal-title":"Biochim Biophys Acta BBA Mol Basis Dis"},{"key":"2840_CR5","unstructured":"Elnahry AG, Tripathy K. Gyrate Atrophy Of The Choroid and Retina. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557759\/. (PMID: 32491691) Accessed: 22 Aug 2022."},{"issue":"4","key":"2840_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0161-6420(81)35031-3","volume":"88","author":"KK Takki","year":"1981","unstructured":"Takki KK, Milton RC. The natural history of gyrate atrophy of the choroid and retina. Ophthalmology. 1981;88(4):292\u2013301.","journal-title":"Ophthalmology"},{"issue":"4","key":"2840_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0161-6420(81)35033-7","volume":"88","author":"MI Kaiser-Kupfer","year":"1981","unstructured":"Kaiser-Kupfer MI, de Monasterio F, Valle D, Walser M, Brusilow S. Visual results of a long-term trial of a low-arginine diet in gyrate atrophy of choroid and retina. Ophthalmology. 1981;88(4):307\u201310.","journal-title":"Ophthalmology"},{"issue":"11","key":"2840_CR8","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1001\/archopht.1991.01080110075039","volume":"109","author":"MI Kaiser-Kupfer","year":"1991","unstructured":"Kaiser-Kupfer MI, Caruso RC, Valle D. Gyrate atrophy of the choroid and retina: long-term reduction of ornithine slows retinal degeneration. Arch Ophthalmol. 1991;109(11):1539\u201348.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2840_CR9","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1073\/pnas.97.3.1224","volume":"97","author":"T Wang","year":"2000","unstructured":"Wang T, Steel G, Milam AH, Valle D. Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. Proc Natl Acad Sci. 2000;97(3):1224\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"7811","key":"2840_CR10","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(73)90667-3","volume":"301","author":"O Simell","year":"1973","unstructured":"Simell O, Takki K. Raised plasma ornithine and gyrate atrophy of the choroid and retina. The Lancet. 1973;301(7811):1031\u20133.","journal-title":"The Lancet"},{"issue":"3","key":"2840_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ophtha.2011.09.017","volume":"119","author":"PI Sergouniotis","year":"2012","unstructured":"Sergouniotis PI, Davidson AE, Lenassi E, Devery SR, Moore AT, Webster AR. Retinal structure, function, and molecular pathologic features in gyrate atrophy. Ophthalmology. 2012;119(3):596\u2013605.","journal-title":"Ophthalmology"},{"issue":"4","key":"2840_CR12","first-page":"432","volume":"24","author":"M Kaiser-Kupfer","year":"1983","unstructured":"Kaiser-Kupfer M, Kuwabara T, Uga S, Takki K, Valle D. Cataract in gyrate atrophy: clinical and morphologic studies. Invest Ophthalmol Vis Sci. 1983;24(4):432\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"2840_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/bjo.76.12.762","volume":"76","author":"D Steel","year":"1992","unstructured":"Steel D, Wood CM, Richardson J, McCarthy J. Anterior subcapsular plaque cataract in hyperornithinaemia gyrate atrophy\u2013a case report. Br J Ophthalmol. 1992;76(12):762.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"2840_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/0301-4738.94055","volume":"60","author":"M Kinori","year":"2012","unstructured":"Kinori M, Desatnik H, Moisseiev J. Bilateral spontaneous dislocation of posterior chamber intraocular lens in a patient with gyrate atrophy. Indian J Ophthalmol. 2012;60(2):133\u20134.","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"2840_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ymgme.2021.07.010","volume":"134","author":"BM Balfoort","year":"2021","unstructured":"Balfoort BM, Buijs MJN, ten Asbroek ALMA, Bergen AAB, Boon CJF, Ferreira EA, et al. A review of treatment modalities in gyrate atrophy of the choroid and retina (GACR). Mol Genet Metab. 2021;134(1):96\u2013116.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2840_CR16","first-page":"311","volume":"88","author":"EL Berson","year":"1981","unstructured":"Berson EL, Shih VE, Sullivan PL. Ocular findings in patients with gyrate atrophy on pyridoxine and low-protein. Low-Arginine Diets Ophthalmology. 1981;88(4):311\u20135.","journal-title":"Low-Arginine Diets Ophthalmology"},{"issue":"8219","key":"2840_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0140-6736(81)92858-0","volume":"317","author":"R Mcinnes","year":"1981","unstructured":"Mcinnes R, Bell L, Arshinoff S, Marliss E, Mcculloch JC. Hyperornithaemia and gyrate atrophy of the retina: improvement of vision during treatment with a low arginine diet. The Lancet. 1981;317(8219):513\u20136.","journal-title":"The Lancet"},{"issue":"7","key":"2840_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ophtha.2017.02.005","volume":"124","author":"RL Taylor","year":"2017","unstructured":"Taylor RL, Parry NRA, Barton SJ, Campbell C, Delaney CM, Ellingford JM, et al. Panel-based clinical genetic testing in 85 children with inherited retinal disease. Ophthalmology. 2017;124(7):985\u201391.","journal-title":"Ophthalmology"},{"issue":"1","key":"2840_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1755-3768.1987.tb08499.x","volume":"65","author":"K Vannas-Sulonen","year":"1987","unstructured":"Vannas-Sulonen K. Progression of gyrate atrophy of the choroid and retina. Acta Ophthalmol (Copenh). 1987;65(1):101\u20139.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"6","key":"2840_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.survophthal.2012.11.006","volume":"58","author":"S Salvatore","year":"2013","unstructured":"Salvatore S, Fishman GA, Genead MA. Treatment of cystic macular lesions in hereditary retinal dystrophies. Surv Ophthalmol. 2013;58(6):560\u201384.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"2840_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0161-6420(81)35030-1","volume":"88","author":"MI Kaiser-Kupfer","year":"1981","unstructured":"Kaiser-Kupfer MI, Kuwabara T, Askanas V, Brody L, Takki K, Dvoretzky I, et al. Systemic manifestations of gyrate atrophy of the choroid and retina. Ophthalmology. 1981;88(4):302\u20136.","journal-title":"Ophthalmology"},{"issue":"1","key":"2840_CR22","first-page":"248","volume":"45","author":"KM Stepien","year":"2022","unstructured":"Stepien KM, Oldham A, Adress F, Wilcox G, Woodall A. Body composition as a tool for monitoring response to creatine supplementation in Gyrate Atrophy. J Inherit Metab Dis. 2022;45(1):248.","journal-title":"J Inherit Metab Dis"},{"key":"2840_CR23","first-page":"159","volume-title":"Clinical ophthalmic genetics and genomics","author":"GCM Black","year":"2022","unstructured":"Black GCM, Ashworth JL, Sergouniotis PI. Genetic disorders affecting the retina, choroid and RPE. In: Black GCM, Ashworth JL, Sergouniotis PI, editors. Clinical ophthalmic genetics and genomics. London: Academic Press; 2022. p. 159\u2013322."},{"key":"2840_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10545-005-0036-7","volume":"28","author":"G Wilcox","year":"2005","unstructured":"Wilcox G, Strauss BJG, Francis DEM, Upton H, Boneh A. Body composition in young adults with inborn errors of protein metabolism\u2014a pilot study. J Inherit Metab Dis. 2005;28:613\u201326.","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02840-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02840-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02840-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T18:15:54Z","timestamp":1700417754000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02840-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2840"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02840-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.02.15.23285700","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval for the study was obtained from the North West Research Ethics Committee (11\/NW\/0421 and 15\/YH\/0365) and all investigations were conducted in accordance with the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"265"}}